ClinicalTrials.Veeva

Menu

Persistent Pulmonary Artery Hypertension After Valve Replacement (SALT)

U

University Hospital Bonn (UKB)

Status

Unknown

Conditions

Persistent Severe PH After Valve Therapy

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01238731
UKB_001_2010

Details and patient eligibility

About

Background: Persistent severe pulmonary hypertension (PH) after mechanical valve replacement is a frequent finding in patients with severe valve-diseases. The reasons to develop PH are multifactorial and the prevalence of severe PH significantly worsens the patients´ outcome.

Aims: (i) To define the prevalence of PH in patients after valve replacement and (ii) to identify factors predicting persistent PH.

Methods: All patients which underwent valve replacement at our institution between the years 2008 -2010 will be screened retrospectively. Those patients with pre- procedural proven PH by means of right-heart catheterization will receive prospective follow-up with echocardiography. Diagnosis of persistent PH will be confirmed with right heart catheterization.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Proven pulmonary hypertension before valve replacement and informed consent for data acquisition

Exclusion criteria

  • patients do not meet inclusion criteria

Trial design

300 participants in 1 patient group

Valve replacement
Description:
Patients undergoing valve replacement for severe valve disease will be screened for study entry

Trial contacts and locations

1

Loading...

Central trial contact

Christoph Hammerstingl, MD; Dirk Skowasch, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems